CausalSentinel

Protein Dossier — HPSE (Heparanase)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Melanoma -0.415 0.126 9.75e-04 Wald ratio 1 cis NA
Body mass index (BMI) -0.0166 0.00535 0.00197 Wald ratio 1 cis NA
Weight -0.0138 0.00472 0.00358 Wald ratio 1 cis NA
Platelet count 2.41 0.876 0.00584 Wald ratio 1 cis NA
Diagnoses - main ICD10: S66 Injury of muscle and tendon at wrist and hand level 0.275 0.103 0.00749 Wald ratio 1 cis NA
Femoral neck bone mineral density 0.0415 0.0165 0.0118 Wald ratio 1 cis NA
LDL cholesterol -0.0257 0.0115 0.025 Wald ratio 1 cis NA
Paget’s disease 0.29 0.134 0.0306 Wald ratio 1 cis NA
Mean platelet volume -0.00499 0.0024 0.0378 Wald ratio 1 cis NA
Cardioembolic stroke -0.141 0.0691 0.0408 Wald ratio 1 cis NA
Mean cell volume 0.113 0.0553 0.0417 Wald ratio 1 cis NA
Parkinson’s disease 0.185 0.0918 0.0438 Wald ratio 1 cis NA
…and 80 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

15 association rows across 12 traits (11 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Serum levels of protein HPSE 2e-133 rs6535455 1 GCST90089086 no MR -> candidate analysis
HPSE protein levels 2e-112 rs61751211 3 GCST90469473 no MR -> candidate analysis
Blood protein levels 8e-78 rs11732810 2 GCST006585 no MR -> candidate analysis
Protrudin levels 7e-41 rs61751211 1 GCST90249121 no MR -> candidate analysis
Heparanase levels 3e-37 rs61751211 1 GCST90247930 no MR -> candidate analysis
Beta-defensin 121 levels 1e-32 rs61751211 1 GCST90246676 no MR -> candidate analysis
Serum levels of protein GCH1 2e-21 rs4693078 1 GCST90086595 no MR -> candidate analysis
Free Cholesterol to Cholesteryl Esters in Large HDL ratio 7e-10 rs79764311 1 GCST90827800 no MR -> candidate analysis
Color vision defects (Deutan-Protan) 2e-6 rs188825767 1 GCST90301670 no MR -> candidate analysis
Crohn’s disease (Tractor method with European ancestry) 3e-6 rs200013026 1 GCST90825978 no MR -> candidate analysis
COVID-19 (covid vs negative) 4e-6 rs72942343 1 GCST90104729 no MR -> candidate analysis
Number of clonal hematopoiesis mutations 7e-6 rs6535458 1 GCST90100218 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 644 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
vitiligo 0.468 common-variant locus no MR -> candidate analysis
lymphangioma 0.416 common-variant locus no MR -> candidate analysis
hemangioma 0.416 common-variant locus no MR -> candidate analysis
Hypercholesterolemia 0.356 common-variant locus MR: beta=-0.0257, p=0.025 (cis)
systemic lupus erythematosus 0.185 common-variant locus MR: beta=-0.109, p=0.279 (cis)

Of the 5 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Heparanase)
gnomAD constraint pLI=1.8e-12, LOEUF=0.937 — LoF-tolerant
GWAS Catalog 32 unique SNPs / 64 rows
ClinVar 151 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance